These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6192185)

  • 21. Relative antiviral activity of in vitro-synthesized murine interferon-alpha 4 and -alpha 1.
    Beilharz MW; Swaminathan N; Lai CM; Pitha PM; Boyer SJ
    J Interferon Res; 1991 Feb; 11(1):9-15. PubMed ID: 1851507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and characterization of anti-murine interferon-gamma sera.
    Havell EA; Spitalny GL
    J Interferon Res; 1983; 3(2):191-8. PubMed ID: 6409971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage colony stimulating factor (CSF-1) blocks the myeloid suppressive but not the antiviral or antiproliferative activities of murine alpha, beta, and gamma interferons in vitro.
    Koren S; Klimpel GR; Fleischmann WR
    J Biol Response Mod; 1986 Dec; 5(6):571-80. PubMed ID: 2432191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral and antiproliferative properties of liposome-associated human interferon-gamma.
    Smith DM; Mayhew E; Reszka R; Ito M; O'Malley JA
    J Interferon Res; 1990 Apr; 10(2):153-60. PubMed ID: 2111353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical modification of mouse interferons.
    Rusckowski M; Paucker M; Dalton B; Ogburn CA
    J Interferon Res; 1982; 2(2):177-85. PubMed ID: 6181175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A; Jaafari MR; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F
    Exp Parasitol; 2009 Apr; 121(4):362-9. PubMed ID: 19211022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of MuIFN-alpha/beta and MuIFN-gamma-induced antiviral states: differential effects with different challenge viruses and lack of correlation with 2'5' oligoadenylate synthetase levels.
    Ramamurthy V; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(1):7-14. PubMed ID: 2845725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of in vivo potentiation resulting from combined interferon therapy: antitumor effect against B-16 melanoma in mice.
    Koren S; Fleischmann WR
    J Interferon Res; 1986 Oct; 6(5):473-82. PubMed ID: 2433361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of murine interferon-alpha 12 (MuIFN-alpha12): biological activities and gene expression.
    Tsang SL; Leung PC; Leung KK; Yau WL; Hardy MP; Mak NK; Leung KN; Fung MC
    Cytokine; 2007 Feb; 37(2):138-49. PubMed ID: 17451966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of mice with macrophage colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta, and gamma interferons.
    Koren S; Klimpel GR; Fleischmann WR
    J Biol Response Mod; 1986 Oct; 5(5):481-9. PubMed ID: 3095498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding and capture of human interferon-alpha by reverse evaporation vesicles, multilamellar vesicles, and small unilamellar vesicles.
    Eppstein DA; Stewart WE
    J Interferon Res; 1981; 1(4):495-504. PubMed ID: 6180083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity.
    Wiranowska M; Prockop LD; Naidu AK; Saporta S; Kori S; Kulkarni AP
    Anticancer Res; 1994; 14(3A):1121-6. PubMed ID: 7521151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild hyperthermia modulates biological activities of interferons.
    Payne J; Nair MP; Ambrus JL; Chadha KC
    Int J Hyperthermia; 2000; 16(6):492-507. PubMed ID: 11129261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of anticellular activity of mouse gamma interferon by an inhibitor of interferon action.
    Fleischmann WR; Kirst CE; Fleischmann CM
    J Interferon Res; 1984; 4(2):193-200. PubMed ID: 6431018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic interactions between IFN-gamma and IFN-beta in priming murine macrophages for tumor cell killing.
    Pace JL
    J Leukoc Biol; 1988 Dec; 44(6):514-20. PubMed ID: 3142957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function analysis of mouse interferon alpha species: MuIFN-alpha 10, a subspecies with low antiviral activity.
    Trapman J; van Heuvel M; de Jonge P; Bosveld IJ; Klaassen P; Zwarthoff EC
    J Gen Virol; 1988 Jan; 69 ( Pt 1)():67-75. PubMed ID: 2826671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function analysis of murine interferon-alpha: antiviral properties of novel hybrid interferons.
    Van Heuvel M; Bosveld IJ; Klaassen P; Zwarthoff EC; Trapman J
    J Interferon Res; 1988 Feb; 8(1):5-14. PubMed ID: 3367062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essentially pure murine interferon-alpha/beta primes poly rI:rC and Sendai virus-induced interferon production in mice.
    Rosztóczy I; Megyeri K
    J Biol Regul Homeost Agents; 1989; 3(1):35-8. PubMed ID: 2472043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody targeted liposomes containing poly(rI).poly(rC) exert a specific antiviral and toxic effect on cells primed with interferons alpha/beta or gamma.
    Milhaud PG; Machy P; Lebleu B; Leserman L
    Biochim Biophys Acta; 1989 Dec; 987(1):15-20. PubMed ID: 2557080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.